v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue:        
Total revenue $ 615 $ 1,667 $ 2,582 $ 3,050
Operating expenses:        
Research and development 10,784 12,990 34,811 37,996
Selling, general, and administrative 5,269 7,682 21,776 23,994
Goodwill impairment 0 181,432 20,950 181,432
Total operating expenses 16,053 202,104 77,537 243,422
Loss from operations (15,438) (200,437) (74,955) (240,372)
Royalty liability interest expense - related parties (9,030) (8,875) (26,075) (25,953)
Other interest income, net 158 160 383 522
Non-operating income, net 1 7,706 417 8,917
Loss before income taxes (24,309) (201,446) (100,230) (256,886)
Income tax benefit (expense) 6 (13) (23) (23)
Net loss (24,303) (201,459) (100,253) (256,909)
Net loss attributable to noncontrolling interest and redeemable noncontrolling interest (762) (21,491) (4,454) (28,623)
Net loss attributable to Cibus, Inc. stockholders $ (23,541) $ (179,968) $ (95,799) $ (228,286)
Basic net loss per share of Class A common stock (in dollars per share) $ (0.44) $ (7.63) $ (2.21) $ (10.33)
Diluted net loss per share of Class A common stock (in dollars per share) $ (0.44) $ (7.63) $ (2.21) $ (10.33)
Weighted average shares of Class A common stock outstanding - basic (in shares) 52,925,776 23,586,746 43,264,590 22,105,979
Weighted average shares of Class A common stock outstanding - diluted (in shares) 52,925,776 23,586,746 43,264,590 22,105,979